Lipopolysacchariden, van S. enterica serotype minnesota Re 595 (Re-mutant)

Lipopolysaccharides (LPS), from S. enterica (Salmonella enterica) serotype minnesota Re 595 (Re mutant) is prepared from Salmonella enterica strain Re 595 (Re mutant) . The structure in the LPS of strain Re 595 was shown to induce secretion and aggregation in human platelets[1]. It is recommended to prepare a solution with concentration ≥2 mg/mL. Vortex thoroughly for more than 10 minutes. Due to the adsorption characteristics of LPS, silanized container or low adsorption centrifuge tubes should be used for aliquoting and storage, and mix thoroughly before use.

LPS, from Salmonella enterica (Serotype minnesota Re 595 (Re mutant) )

12352200

Bacterial; Toll-like Receptor (TLR)

Anti-infection; Immunology/Inflammation

Inflammation/Immunology

[Lipopolysaccharides,fromS.entericaserotypeminnesotaRe595(Remutant)]

[1]Timmons S, et al. Mechanism of human platelet activation by endotoxic glycolipid-bearing mutant Re595 of Salmonella minnesota. Blood. 1986 Nov;68 (5) :1015-23.

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

http://file.medchemexpress.com/batch_PDF/HY-D1056C5/Lipopolysaccharides-from-S-enterica-serotype-minnesota-Re-595-Re-mutant-SDS-MedChemExpress.pdf

Biochemical Assay Reagents

No Development Reported